StemCells Incorporated

Type: Company
Name: StemCells Incorporated
First reported 23 hours ago - Updated 23 hours ago - 1 reports

Christopher James Turns a Clinical Eye on Biotechs with High Reward Potential

A biotech analyst could play it safe, and stick with mid-, late- and commercial-stage companies that offer higher odds and decent returns on good news. Christopher James, on the other hand, recommends that investors willing to diversify their holdings ... [Published Stockboard Media Inc. - 23 hours ago]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

California Hispanic Chambers of Commerce Weighs In on Gov. Brown’s Trip to Mexico

Los Angeles Times: Flawed Investigation Magnifies California Stem Cell ScandalThe Los Angeles Times will have a column again this Sunday excoriating the $3 billion California stem cell agency, and it will involve the same set of players, the agency’s ... [Published Fox40 KTXL - Jul 29 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

StemCells, Inc., and the Quest for a Cure

For the people of StemCells, Inc., one of the most respected stem-cell companies in America, the work they do is more than just a job. They are fighting to ease suffering and save lives. When they use stem cells to challenge spinal-cord injury, it is ... [Published Huffington Post - Jul 29 2014]
First reported Jul 26 2014 - Updated Jul 26 2014 - 1 reports

California stem cell agency head takes stand on 'personal ethics'

The California Institute for Regenerative Medicine has continued in damage-control mode since the state agency’s former president, Alan Trounson, joined the board of directors at StemCells Inc. this month, just seven days after leaving the agency. ... [Published Greenspace - Jul 26 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

West Coast Biotech Roundup: IPOs, Gilead, Sofinnova, & Denouements

What a week to round up. Against a backdrop of regulatory approvals, strategic deals, and R&D initiatives, a fresh salvo of life sciences IPOs signaled a resurgence in public offerings already running ahead of last year’s pace. We also saw moves to resolve ... [Published Xconomy - Jul 25 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

CIRM Leader Takes Steps To Avoid Conflicts of Interest

The president and CEO of the California Institute for Regenerative Medicine says that he will not accept gifts or other compensation from any group that receives funding from the agency. In addition, he will not accept job offers from such groups for ... [Published California Healthline - Jul 25 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 2 reports

Controversial board move doesn't stop StemCells from raising $20 million

StemCells Inc., wrapped in a controversy around the departed president of California's stem cell research funding agency, plans to raise $20 million by selling stock and warrants to what it identifies as "two well-recognized institutional biotechnology ... [Published Business First of Buffalo - Jul 15 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 3 reports

Sector Update: Health Care Stocks Falling Late; StemCells Declines Over 10% On Plans for $20 Mln Stock Sale

PFE +0.63%ABT -1.00%MRK -0.43%AMGN -1.81%Health care stocks were mostly lower today with the NYSE Healthcare Sector Index sliding nearly 0.7% while shares of health care companies in the S&P 500 were down 0.9% as a group.In company news, StemCells Inc. ... [Published Nasdaq - Jul 15 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 3 reports

California stem cell agency to review dealings with StemCells Inc.

The move has an appearance of a serious conflict of interest, said John M. Simpson, director of the stem cell project for Santa Monica-based nonprofit Consumer Watchdog, in an interview.“The thing smacks as if this is StemCells Inc. giving a payback to ... [Published Los Angeles Times - Jul 11 2014]
First reported Jul 09 2014 - Updated Jul 10 2014 - 3 reports

West Coast Biotech Roundup: Scripps, Trounson, Versant, Gilead, & More

The big news out west this week revolves around institutional drama. In San Diego, the faculty at the Scripps Research Institute has taken issue with merger talks that the president and board have had with the University of Southern California. The Union-Tribune ... [Published Xconomy - Jul 10 2014]
First reported Jul 08 2014 - Updated Jul 09 2014 - 4 reports

California Stem Cell Crony Capitalism

Color me wondering why it took so long: The former head of the California Institute for Regenerative Medicine–once in charge of giving away billions of dollars of borrowed taxpayers’ money–has joined a company to which the CIRM gave a big grant. From ... [Published National Review - Jul 09 2014]
First reported Jul 07 2014 - Updated Jul 08 2014 - 4 reports

StemCells elects Dr Alan Trounson to board

Cell therapeutics company StemCells (NasdaqCM:STEM) revealed on Monday the addition of Dr Alan Trounson, PhD to its board of directors. Most recently, Dr Trounson has served as president of The California Institute of Regenerative Medicine (CIRM), a scientific ... [Published Individual.com - Jul 08 2014]

Quotes

"We are very excited aboutRexahn Pharmaceuticals Inc.; it's an early-stage oncology company with multiple shots on goal."
...The company is being sued by a former employee, Rob Williams . In his complaint, Williams alleges that he "noted poor sterile technique, failure to adhere to current Good Manufacturing Practices in the company's manufacturing process, and substantial deficiencies in the company's Manual Aseptic Processing of HuCNS-SC (Human Central Nervous System Stem Cells) cell lines...."
"I believe that we can now put this behind us and focus on developing the cures that patients so much need" said Joe Panetta, a board member who is president and chief executive of Biocom, a San Diego-based life sciences trade group
...upon the strength of our interim clinical data, and our ongoing translation agenda," said Greg Schiffman, chief financial officer of StemCells Inc. "Moreover, this transaction was structured with a short term warrant which provides the investors with the potential to provide approximately $20 million in additional capital next year. The proceeds from this financing, combined with the funds from the warrants, should they be exercised, would provide sufficient capital to finance our projected 2015 operating expenditures, by which time we expect to have final data from our Phase I II clinical programs in spinal cord injury and dry age related macular degeneration and should have initiated controlled proof of concept Phase II clinical programs in both of these indications."

More Content

All (99) | News (70) | Reports (0) | Blogs (7) | Audio/Video (0) | Fact Sheets (1) | Press Releases (21)
sort by: Date | Relevance
Christopher James Turns a Clinical Eye on Biote... [Published Stockboard Media Inc. - 23 hours ago]
California Hispanic Chambers of Commerce Weighs... [Published Fox40 KTXL - Jul 29 2014]
StemCells, Inc., and the Quest for a Cure [Published Huffington Post - Jul 29 2014]
California stem cell agency head takes stand on... [Published Greenspace - Jul 26 2014]
West Coast Biotech Roundup: IPOs, Gilead, Sofin... [Published Xconomy - Jul 25 2014]
CIRM Leader Takes Steps To Avoid Conflicts of I... [Published California Healthline - Jul 25 2014]
Stem Cell Therapy Market to grow at a CAGR of 3... [Published MyNewsDesk - Jul 25 2014]
Stem cell agency tightens ethics rules [Published U-T San Diego - Jul 24 2014]
STEMCELLS INC FILES (8-K) Disclosing Other Even... [Published Industrial Info Financials - Jul 22 2014]
StemCells Inc. Announces Closing Of $20 Million... [Published BioPortfolio - Jul 21 2014]
StemCells concludes sale of 11.3m units [Published TradingCharts.com - Jul 21 2014]
Santa Clara Whistleblower Sues Newark Stem Cell... [Published CBS San Francisco - Jul 19 2014]
StemCells Inc announces closing of $20 mln offe... [Published Reuters - Jul 18 2014]
StemCells, Inc. Announces Closing of $20 Millio... [Published Wall Street Select - Jul 18 2014]
StemCells, Inc. Announces Closing of $20 Millio... [Published GlobeNewswire: Acquisitions News - Jul 18 2014]
Lawsuit Claims Stem Cells Unsafe [Published The Scientist - Jul 18 2014]
Newark: Whistleblower lawsuit against stem cell... [Published Inside Bay Area - Jul 17 2014]
Hal Mintz And Sabby Capital Disclose New Invest... [Published InsiderMonkey.com - Jul 17 2014]
Healthcare Review: Skystar Bio-Pharmaceutical, ... [Published BioMedReports - Jul 16 2014]
Whistleblower Alarmed at Stem Cell Work [Published Courthouse News Service - Jul 16 2014]
StemCells nets $18.8mm via PIPE [Published BioPortfolio - Jul 16 2014]
Lipocine Announces Issuance Of U.S. Patent For ... [Published BioMedReports - Jul 16 2014]
Controversial board move doesn't stop StemCells... [Published Business First of Buffalo - Jul 15 2014]
Sector Update: Health Care Stocks Falling Late;... [Published Nasdaq - Jul 15 2014]
Why StemCells (STEM) Stock Is Down Today [Published The Street Latest - Jul 15 2014]
Morning Market Losers [Published Benzinga.com - Jul 15 2014]
BUZZ-U.S. Stocks on the Move-Rockwood, La Jolla... [Published London South East - Jul 15 2014]
StemCells Inc announces proposed $20 mln offering [Published Reuters - Jul 15 2014]
StemCells, Inc. Announces Proposed $20 Million ... [Published GlobeNewswire: Advertising News - Jul 15 2014]
StemCells, Inc. Announces Proposed $20 Million ... [Published EMoneyDaily - Jul 15 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
California stem cell agency head takes stand on... [Published Greenspace - Jul 26 2014]
The California Institute for Regenerative Medicine has continued in damage-control mode since the state agency’s former president, Alan Trounson, joined the board of directors at StemCells Inc. this month, just seven days after leaving the agency. ...
California stem cell agency to review dealings ... [Published Greenspace - Jul 11 2014]
California’s stem cell agency announced Wednesday it was taking steps to deal with a “risk of conflict of interest” two days after its former president took a position with a company that the state agency had been funding. ...
California stem cell agency to review dealings ... [Published Top of the Ticket - Jul 11 2014]
California’s stem cell agency announced Wednesday it was taking steps to deal with a “risk of conflict of interest” two days after its former president took a position with a company that the state agency had been funding. ...
Stem cell agency outlines steps to prevent “pot... [Published Tech Chronicles - Jul 09 2014]
Two days after the ex-president of California’s stem cell agency became a board director at a company that is receiving funding from the agency, the agency said Wednesday it is taking steps to “mitigate a potential conflict of interest.” Earlier this ...
Ex-president of California stem cell agency now... [Published Tech Chronicles - Jul 08 2014]
StemCells Inc.’s board of directors now includes the former president of the California stem cell agency that gave the company $19.4 million in research funding. StemCells Inc., a Newark company developing stem cell-based therapies, said Monday Dr. Alan ...
1 2

Press Releases

sort by: Date | Relevance
StemCells, Inc. Announces Closing of $20 Millio... [Published GlobeNewswire: Acquisitions News - Jul 18 2014]
StemCells, Inc. Announces Proposed $20 Million ... [Published GlobeNewswire: Advertising News - Jul 15 2014]
StemCells, Inc. Appoints Dr. Alan Trounson to B... [Published GlobeNewswire: Advertising News - Jul 07 2014]
Agreements, NDA Submissions, FDA Approvals, Enr... [Published Financial Services - Jul 07 2014]
Biotechnology Equities Technical Notes -- Resea... [Published Financial Services - Jun 26 2014]
1 2 3 4 5
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.